Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.
Important takeaways for all competitive exams:
National News India Approves Anhydrous Ammonia Fertilizer to Boost Sustainable Farming India has approved the…
The Reserve Bank of India (RBI) got permission from the Indian Government to roll out…
The e-Zero FIR system has been introduced by the Gujarat Government to facilitate cyber financial…
Gujarat has secured its position as a frontrunner among India’s states with Geographical Indication (GI)…
On 29th July, 2026 International Tiger Day will be observed worldwide, to raise the global…
In July 2026, Sarnath got included in the UNESCO World Heritage List which helped Uttar…